Royal Philips Electronics and GlyGenix Therapeutics, Inc. announced a joint research agreement to explore the feasibility of using ultrasound technologies for gene therapy.
Royal Philips Electronics and GlyGenix Therapeutics, Inc. announced a joint research agreement to explore the feasibility of using ultrasound technologies for gene therapy.